[ad_1]
Following a successful NHS trial, an electric headset designed to help treat depression has been endorsed for broader use in managing the condition. However, the long-term effects of the device remain uncertain.
The NHS has recommended expanding the use of an innovative electric headset that treats depression after trial results demonstrated its effectiveness in reducing symptoms.
Developed by Flow Neuroscience, the headset was prescribed by GPs to depression patients who used it for 30 minutes each day over a six-week period. This non-invasive treatment method employs transcranial direct current stimulation, or tDCS.
The electric stimulation targets the frontal brain areas involved in mood regulation.
The trial indicated that 58% of participants experienced symptom improvement within six weeks, and one-third achieved remission, showing no clinical depression signs.
Flow Neuroscience markets the device as the “first and only medically approved at-home depression treatment,” which can complement other therapies, including medication and psychotherapy.
Northamptonshire NHS Foundations Trust conducted the trial, and the device is also available for private purchase at a cost of £399.
One trial participant, James Maynard, who has dealt with depression, shared his experience with Sky News.
“I felt extremely low, without any clear goals, living life on autopilot—going to work, caring for the children, struggling with sleep if I could manage to get any,” Maynard explained.
“After consistently wearing the device for 30 minutes a day for a few weeks, I noticed significant improvements.”
Maynard noted, “I began to sleep better. Even my wife mentioned that I seemed happier and that I wasn’t waking up irritable anymore. Clearly, something positive was happening.”
James Maynard, who has struggled with depression and is using the headset
“For many years, the only options were medication or cognitive behavioural therapy. This treatment is an innovative addition,” Dr Zafar said.
The long-term impacts of the headset on depression beyond six weeks have not yet been determined.
More stories from Sky News:
The embrace of forest bathing as ecotherapy
Apologies from a Tory candidate over insensitive joke about date rape drugs
Premature celebration costs athlete a race win
Stay updated with the chief UK and global stories by following Sky News
GP Dr Anita Raja spoke to Sky News, emphasizing the importance of understanding the potential for relapse in mental health patients once treatment ceases or is suspended.
“While the device shows promise, we are keen to ascertain the outcomes post-usage—whether patients might relapse into depression,” Dr Raja expressed.
[ad_2]
Frequently Asked Questions (FAQ)
What is the main function of the electric headset?
The headset employs transcranial direct current stimulation (tDCS) to stimulate the frontal areas of the brain responsible for emotional regulation, which can help reduce depression symptoms.
How long was the headset used in the NHS trial?
Patients used the headset for 30 minutes per day over a period of six weeks.
What were the results of the NHS trial?
58% of trial participants saw improvements in their depression symptoms within six weeks, and one-third achieved remission with no signs of depression.
Can the headset be used alongside other treatments?
Yes, the headset is marketed as a complementary treatment that can be used alongside medications and talking therapies.
Is the electric headset available for purchase?
Yes, the electric headset can be purchased privately for £399.
Are there any known long-term benefits of the device?
The long-term benefits of the headset have not yet been determined; the trial focused on short-term usage up to six weeks.
